Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON60311Phase 3Recruiting
Phase 3, randomised, open-label trial of clindamycin and gentamicin in appendicitis (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Incidence of postoperative intra-abdominal abscess. Started Feb 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON60311.